Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
Authors
Keywords
B7-H6, HCC, Immunohistochemistry, RNAi, Cancer progression
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-04
DOI
10.1186/s12935-018-0627-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas
- (2018) Fengyuan Che et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells
- (2018) Suresh Bugide et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection
- (2018) Yean K. Yong et al. Frontiers in Immunology
- Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
- (2017) Xiaoyan Li et al. Journal of Translational Medicine
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- The B7 Family Member B7-H6: a New Bane of Tumor
- (2017) Ying Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer
- (2017) Jing Sun et al. Oncology Letters
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3
- (2016) Qi Zhou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
- (2016) FEIFEI WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
- (2016) Sylvie Rusakiewicz et al. OncoImmunology
- Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer
- (2016) Zhenyu Xu et al. OncoImmunology
- B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity
- (2015) Ming-Ru Wu et al. JOURNAL OF IMMUNOLOGY
- NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure
- (2015) Yong Zou et al. PLoS One
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer
- (2012) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma
- (2011) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started